Richard D. Pilnik, Director at DiaMedica Therapeutics Inc. (DMAC), bought 7,840 shares at $2.56 ($20K) on 2019-08-16, disclosed to the SEC on 2019-08-19.
Open-market purchase of $20k DMAC by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| DMAC | BUY | 2021-08-17 | $49K | — | Filing → |
| DMAC | BUY | 2020-12-04 | $54K | — | Filing → |
| DMAC | BUY | 2019-05-31 | $53K | — | Filing → |